Insider sales at 0.009% of market cap are economically meaningless, no actionable signal. Monitor next quarterly filing for any fundamental deterioration, but this cluster does not warrant any position adjustment.
LH drugs
LH drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 18 $322.18entry
- T+1 · 3mo ago +2.56%α +2.35% · $330.44
- T+5 · 3mo ago +4.81%α +5.01% · $337.68
- T+20 · 2mo ago +0.72%α +2.03% · $324.51
- T+60 · 6d ago +15.53%α +16.53% · $372.23
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
President & CEO Adam H. Schechter and Director Kerrii B. Anderson executed open-market sales totaling $2.45M (0.009% of market cap) over a one-week window. The CEO sale represents the largest insider disposal at LH in the past 30 days. The absolute dollar value is immaterial relative to the $26.2B market cap, indicating routine portfolio diversification rather than informed bearish conviction.
Key Financial Metrics
Key Facts
- President & CEO Adam H. Schechter sold 4,700 shares at $320.37 on 2026-08-11 for $1.50M
- Director Kerrii B. Anderson sold 3,000 shares at $318.02 on 2026-08-17 for $954K
- Total cluster value of $2.45M represents only 0.009% of LH's $26.2B market cap
- Both transactions are open-market sales (Code S), not tax-withholding or exercise-related
Financial Impact
Cluster value $2.45M is 0.009% of $26.2B market cap, trivial by proportionality standards
Risk Factors
- CEO selling close to earnings season could signal internal bearishness despite immaterial size
- No insider buying to offset the sales, one-sided selling pattern may persist
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-LH-1787120039190 |
Track record
29 reports on LH
5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +17.60% at T+60 after the Apr 30, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $372.32 Now $372.46 +0.04% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $372.23 Now $372.46 +0.06% settles Nov 18
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $363.30 to $372.32 Now $372.46 +2.52% ▲ +2.48% −0.81% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 4, 202612d ago 8-K Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $353.92 to $370.88 Now $372.46 +5.24% ▲ +4.79% +5.38% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $361.39 to $366.57 Now $372.46 +3.06% ▲ +1.43% +4.14% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $360.25 to $367.79 Now $372.46 +3.39% ▲ +2.09% +2.81% vs SPY
- Oct 26, 202621d ago Institutional Cluster Neutral 3/10 Entry $329.90 to $361.39 Now $372.46 +12.90% ▲ +9.55% +10.81% vs SPY
- Oct 21, 202626d ago 8-K Neutral 2/10 Entry $323.75 to $331.17 Now $372.46 +15.05% ▲ +2.29% +2.74% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers